Narmafotinib
Narmafotinib (AMP-945) is an orally active inhibitor of the enzyme focal adhesion kinase (FAK, KD=0.21 nM) . Narmafotinib inhibits autophosphorylation of 397Y-FAK in MDA-MB-231 cells with an IC50=7 nM and exhibits low general cellular toxicity (IC50=2.7 μM, MDA-MB-231 cells) . Narmafotinib can be used for anti-cancer study[1].
Product Specifications
CAS Number
1393653-34-3
Product Name Alternative
AMP-945
UNSPSC
12352005
Target
FAK
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/narmafotinib.html
Concentration
10mM
Purity
99.86
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(CC1=C(CCC2=NC(NC3=CC=C(C4CCN(CC4)C)C=C3OC)=NC=C2C(F)(F)F)C=CC=C1)N
Molecular Formula
C28H32F3N5O2
Molecular Weight
527.58
References & Citations
[1]Amplia Therapeutics completes single-dose study of AMP945|[2]Street I, et al. Abstract LB-308: combination of CTx-0294945 a highly selective inhibitor of focal adhesion kinase with bevacizumab in pre-clinical models of breast cancer[J]. Cancer Research, 2012, 72 (8_Supplement) : LB-308-LB-308.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
PKSM041213-01 10 µg
Recombinant Mouse SynCam/CADM1 Protein (Fc Tag)
Sign In for Pricing
View Details PKSM041213-02 50 µg
Recombinant Mouse SynCam/CADM1 Protein (Fc Tag)
Sign In for Pricing
View Details 
TRC-D525663-500MG 500 mg
Dodecylbenzenesulfonic Acid (70 wt. % in isopropanol, Technical grade, Mixture of different chain lengths)
Sign In for Pricing
View Details 